Ilaris
canakinumab
Cryopyrin-Associated Periodic Syndromes
Arthritis, Juvenile Rheumatoid
Arthritis, Gouty
Date of authorisation:
Revision: 31
Last updated:
MedicineHumanAuthorised
EMEA-000060-PIP09-20 - paediatric investigation plan
Decision type: W: decision granting a waiver in all age groups for all conditions or indications
Therapeutic area: Immunology-Rheumatology-Transplantation
PIP number: P/0075/2021
Route(s) of administration: Subcutaneous use
Pharmaceutical form(s):
Powder for solution for injection
Solution for injection
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
Credelio Plus
lotilaner / milbemycin oxime
Dogs
Date of authorisation:
Last updated:
MedicineVeterinaryAuthorised
EMEA-000060-PIP08-19 - paediatric investigation plan
Decision type: W: decision granting a waiver in all age groups for all conditions or indications
Therapeutic area: Oncology
PIP number: P/0029/2020
Route(s) of administration: Subcutaneous use
Pharmaceutical form(s):
Powder for solution for injection
Solution for injection
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
EMEA-000060-PIP07-19 - paediatric investigation plan
Decision type: W: decision granting a waiver in all age groups for all conditions or indications
Therapeutic area: Immunology-Rheumatology-Transplantation
PIP number: P/0366/2019
Route(s) of administration: Subcutaneous use
Pharmaceutical form(s):
Powder for solution for injection
Solution for injection
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
EMEA-000060-PIP04-14-M01 - paediatric investigation plan
Decision type: PM: decision on the application for modification of an agreed PIP
Therapeutic area: Immunology-Rheumatology-Transplantation
PIP number: P/0057/2015
Route(s) of administration: Subcutaneous use
Pharmaceutical form(s):
Solution for injection
Powder for solution for injection
Powder and solvent for solution for injection
Decision date:
Last updated:
Compliance check: ✔
PIPHuman
EMEA-000060-PIP05-14-M01 - paediatric investigation plan
Decision type: PM: decision on the application for modification of an agreed PIP
Therapeutic area: Immunology-Rheumatology-Transplantation
PIP number: P/0239/2015
Route(s) of administration: Subcutaneous use
Pharmaceutical form(s):
Solution for injection
Powder for solution for injection
Powder and solvent for solution for injection
Decision date:
Last updated:
Compliance check: ✔
PIPHuman
EMEA-000060-PIP02-08-M06 - paediatric investigation plan
Decision type: PM: decision on the application for modification of an agreed PIP
Therapeutic area: Immunology-Rheumatology-Transplantation
PIP number: P/0141/2013
Route(s) of administration: Subcutaneous use
Pharmaceutical form(s):
Powder for solution for injection
Powder and solvent for solution for injection
Solution for injection in pre-filled syringe
Decision date:
Last updated:
Compliance check: ✔
PIPHuman